|
humans |
39 |
|
female |
33 |
|
middle aged |
23 |
|
adult |
22 |
|
aged |
21 |
|
animals |
17 |
|
immunohistochemistry |
17 |
|
cervical cancer |
16 |
|
gene expression regulation, neoplastic |
15 |
|
hong kong - epidemiology |
15 |
|
reverse transcriptase polymerase chain reaction |
15 |
|
cohort studies |
14 |
|
ovarian cancer |
14 |
|
pregnancy |
14 |
|
neoplasm staging |
13 |
|
apoptosis |
12 |
|
genetic predisposition to disease |
12 |
|
prognosis |
12 |
|
tumor cells, cultured |
12 |
|
adolescent |
11 |
|
blotting, western |
11 |
|
case-control studies |
11 |
|
cell adhesion molecules - genetics - metabolism |
11 |
|
cell line, tumor |
11 |
|
cercopithecus aethiops |
11 |
|
cho cells - virology |
11 |
|
coronavirus |
11 |
|
cricetinae |
11 |
|
cricetulus |
11 |
|
gestational trophoblastic disease |
11 |
|
homozygote |
11 |
|
intestine, small - physiology |
11 |
|
lectins, c-type - genetics - metabolism |
11 |
|
lung - physiology - virology |
11 |
|
molecular sequence data |
11 |
|
proteasome endopeptidase complex - metabolism |
11 |
|
receptors, cell surface - genetics - metabolism |
11 |
|
risk factors |
11 |
|
rna, messenger - metabolism |
11 |
|
sars coronavirus |
11 |
|
sars virus - metabolism - pathogenicity |
11 |
|
severe acute respiratory syndrome - epidemiology - genetics |
11 |
|
species index: animalia |
11 |
|
tandem repeat sequences |
11 |
|
vero cells - virology |
11 |
|
aged, 80 and over |
10 |
|
cell proliferation |
10 |
|
dna methylation |
10 |
|
polymerase chain reaction |
10 |
|
tumor markers, biological - analysis |
10 |
|
breast cancer |
9 |
|
diagnosis, differential |
9 |
|
endometrial cancer |
9 |
|
genes, tumor suppressor |
9 |
|
genotype |
9 |
|
hydatidiform mole |
9 |
|
phosphorylation |
9 |
|
promoter regions, genetic |
9 |
|
survival analysis |
9 |
|
choriocarcinoma |
8 |
|
disease progression |
8 |
|
dna primers |
8 |
|
endometrial carcinoma |
8 |
|
gli1 |
8 |
|
mutation - genetics |
8 |
|
ovarian neoplasms - genetics - metabolism - pathology |
8 |
|
signal transduction |
8 |
|
tumor markers, biological - metabolism |
8 |
|
cell cycle proteins - analysis |
7 |
|
dna, viral - genetics |
7 |
|
gene amplification |
7 |
|
gene expression profiling |
7 |
|
hedgehog |
7 |
|
human papillomavirus |
7 |
|
hydatidiform mole - metabolism - pathology |
7 |
|
methylation |
7 |
|
ovarian neoplasms - metabolism - pathology |
7 |
|
placenta - metabolism |
7 |
|
proliferation |
7 |
|
repressor proteins - biosynthesis |
7 |
|
retrospective studies |
7 |
|
adenocarcinoma - genetics - metabolism - pathology |
6 |
|
apoptosis - drug effects - physiology |
6 |
|
c-mos |
6 |
|
carcinoma, squamous cell - genetics |
6 |
|
carcinoma, squamous cell - genetics - virology |
6 |
|
caspases - metabolism |
6 |
|
cell adhesion - physiology |
6 |
|
cell line, transformed |
6 |
|
cell nucleus - metabolism |
6 |
|
cell proliferation - drug effects |
6 |
|
cervical intraepithelial neoplasia |
6 |
|
china |
6 |
|
chromosome in situ hybridization |
6 |
|
cisplatin - pharmacology |
6 |
|
comparative genomic hybridization |
6 |
|
cpg islands |
6 |
|
cyclin-dependent kinase inhibitor p21 |
6 |
|
dna mutational analysis |
6 |
|
dna, neoplasm - genetics |
6 |
|
drug resistance, neoplasm |
6 |
|
dual specificity phosphatase 6 - antagonists & inhibitors - genetics - metabolism |
6 |
|
follow-up studies |
6 |
|
genes, p53 |
6 |
|
genital neoplasms, female - genetics |
6 |
|
genital neoplasms, female - metabolism - pathology |
6 |
|
germ cell tumor |
6 |
|
gestational trophoblastic disease - metabolism - pathology |
6 |
|
gynecological neoplasm |
6 |
|
hedgehog proteins - genetics - metabolism |
6 |
|
helix-loop-helix motifs |
6 |
|
hpv |
6 |
|
hydrogen peroxide - metabolism |
6 |
|
id proteins |
6 |
|
immunoenzyme techniques |
6 |
|
inhibitor of differentiation protein 1 |
6 |
|
karyotyping |
6 |
|
ki67 |
6 |
|
mice |
6 |
|
microdissection |
6 |
|
microsatellite repeats - genetics |
6 |
|
mitogen-activated protein kinase 1 - antagonists & inhibitors - metabolism |
6 |
|
mitogen-activated protein kinase 3 - antagonists & inhibitors - metabolism |
6 |
|
mutation |
6 |
|
nuclear proteins - genetics - metabolism |
6 |
|
oligonucleotide array sequence analysis |
6 |
|
ovarian carcinoma |
6 |
|
ovarian neoplasms - drug therapy - genetics - pathology |
6 |
|
oxidative stress - physiology |
6 |
|
p53 |
6 |
|
placenta - chemistry |
6 |
|
prevalence |
6 |
|
proto-oncogene proteins c-mos - biosynthesis |
6 |
|
reproducibility of results |
6 |
|
rna, messenger - antagonists & inhibitors - genetics - metabolism |
6 |
|
sequence analysis, dna |
6 |
|
signal transduction - drug effects |
6 |
|
transcription factors - biosynthesis |
6 |
|
transcription factors - genetics - metabolism |
6 |
|
trophoblasts - chemistry - pathology |
6 |
|
tumor suppressor protein p53 - analysis |
6 |
|
tumourigenicity |
6 |
|
ubiquitin - metabolism |
6 |
|
uterine cervical neoplasms - genetics |
6 |
|
uterine cervical neoplasms - genetics - metabolism - pathology |
6 |
|
vaginal smears |
6 |
|
vulvar neoplasms - genetics - virology |
6 |
|
zic2 |
6 |
|
adenocarcinoma, clear cell - genetics - metabolism - pathology |
5 |
|
antimetabolites, antineoplastic - pharmacology |
5 |
|
apoptosis regulatory proteins |
5 |
|
apoptosis regulatory proteins - genetics - metabolism |
5 |
|
azacitidine - analogs & derivatives - pharmacology |
5 |
|
base sequence |
5 |
|
biological markers - analysis |
5 |
|
biopsy |
5 |
|
blotting, western - methods |
5 |
|
blu |
5 |
|
breast neoplasms - diagnosis - prevention & control |
5 |
|
calcium-calmodulin-dependent protein kinases - genetics |
5 |
|
carcinoma, endometrioid - enzymology - genetics |
5 |
|
carcinoma, endometrioid - enzymology - genetics - metabolism - pathology |
5 |
|
carcinoma, endometrioid - enzymology - genetics - pathology |
5 |
|
carcinoma, endometrioid - genetics - metabolism - pathology |
5 |
|
carcinoma, squamous cell - ethnology - genetics - virology |
5 |
|
carcinosarcoma |
5 |
|
cd55 |
5 |
|
cdna microarray |
5 |
|
cell cycle proteins |
5 |
|
cell cycle proteins - analysis - genetics |
5 |
|
cell differentiation |
5 |
|
cell migration |
5 |
|
cervical intraepithelial neoplasia - ethnology - genetics - virology |
5 |
|
cervix uteri - chemistry - metabolism |
5 |
|
cervix uteri - virology |
5 |
|
chinese |
5 |
|
chromosome aberrations |
5 |
|
chromosome painting |
5 |
|
confidence intervals |
5 |
|
cyclin-dependent kinase inhibitor p21 - antagonists and inhibitors - genetics |
5 |
|
cystadenocarcinoma, mucinous - genetics - metabolism - pathology |
5 |
|
cystadenocarcinoma, serous - genetics - metabolism - pathology |
5 |
|
cytogenetic analysis - methods |
5 |
|
dalys |
5 |
|
dapk |
5 |
|
dna hypermethylation |
5 |
|
dna replication |
5 |
|
dna, neoplasm - blood |
5 |
|
dna, neoplasm - chemistry - genetics - metabolism |
5 |
|
dna, viral - analysis |
5 |
|
dna-binding proteins |
5 |
|
dna-binding proteins - analysis |
5 |
|
dnmt1 |
5 |
|
e-cadherin |
5 |
|
endometrial neoplasms - enzymology - genetics |
5 |
|
endometrial neoplasms - enzymology - genetics - metabolism - pathology |
5 |
|
endometrial neoplasms - enzymology - genetics - pathology |
5 |
|
endometrial neoplasms - metabolism - pathology |
5 |
|
endometrial stromal sarcoma |
5 |
|
estrogen receptors |
5 |
|
forkhead transcription factors - analysis - genetics |
5 |
|
forkhead transcription factors - analysis - genetics - physiology |
5 |
|
foxg1 |
5 |
|
foxm1 |
5 |
|
gene expression |
5 |
|
gene expression regulation, enzymologic |
5 |
|
gene frequency |
5 |
|
genes, p16 |
5 |
|
genes, p53 - genetics |
5 |
|
genes, ras |
5 |
|
genes, viral - genetics |
5 |
|
genetic predisposition to disease - genetics |
5 |
|
genotyping |
5 |
|
gestational trophoblastic neoplasia |
5 |
|
glutathione s-transferase pi |
5 |
|
glutathione transferase - analysis - genetics - metabolism |
5 |
|
glutathione transferase - genetics |
5 |
|
gynecological cancer |
5 |
|
hdab2ip |
5 |
|
health care surveys |
5 |
|
hong kong |
5 |
|
hormonal treatment |
5 |
|
hpv‐e6 |
5 |
|
human papillomavirus 16 - genetics |
5 |
|
human papillomavirus 18 - genetics |
5 |
|
hydatidiform mole - diagnosis - genetics - pathology |
5 |
|
hydatidiform mole - genetics - pathology - surgery |
5 |
|
iatrogenesis |
5 |
|
iatrogenic disease - epidemiology |
5 |
|
immunohistochemical staining |
5 |
|
in situ hybridization |
5 |
|
in situ hybridization - methods |
5 |
|
intracellular signaling peptides and proteins |
5 |
|
isoenzymes - genetics |
5 |
|
keratins - metabolism |
5 |
|
ki-67 antigen - analysis |
5 |
|
ki-67 antigen - biosynthesis |
5 |
|
leiomyosarcoma |
5 |
|
loss of heterozygosity |
5 |
|
male |
5 |
|
mass screening - utilization |
5 |
|
mcm7 |
5 |
|
medical sciences |
5 |
|
metastatic partial mole |
5 |
|
mgmt |
5 |
|
microsatellite repeats |
5 |
|
minichromosome maintenance protein 7 (mcm7) |
5 |
|
multivariate analysis |
5 |
|
neoplasm invasiveness |
5 |
|
neoplasm metastasis |
5 |
|
nerve tissue proteins - analysis - genetics - physiology |
5 |
|
nuclear proteins |
5 |
|
nuclear proteins - analysis |
5 |
|
o(6)-methylguanine-dna methyltransferase - genetics |
5 |
|
odds ratio |
5 |
|
oncogenes - genetics |
5 |
|
ovarian neoplasms - drug therapy - pathology |
5 |
|
ovarian neoplasms - genetics |
5 |
|
ovarian neoplasms - genetics - pathology |
5 |
|
ovary - metabolism - pathology |
5 |
|
p16 |
5 |
|
p21waf1/cip1 |
5 |
|
p63 |
5 |
|
papillomaviridae - classification - isolation & purification |
5 |
|
papillomaviridae - isolation & purification |
5 |
|
papillomavirus infections - diagnosis - virology |
5 |
|
papillomavirus infections - ethnology - genetics |
5 |
|
pcna |
5 |
|
pet/ct |
5 |
|
phenotype |
5 |
|
placenta - metabolism - pathology |
5 |
|
ploidies |
5 |
|
polymorphism, genetic |
5 |
|
polymorphism, restriction fragment length |
5 |
|
polymorphism, single nucleotide |
5 |
|
precancerous conditions - ethnology - genetics - virology |
5 |
|
proliferating cell nuclear antigen - biosynthesis |
5 |
|
promoter cpg island hypermethylation |
5 |
|
promoter regions, genetic - genetics |
5 |
|
proteins - genetics |
5 |
|
proteins - metabolism |
5 |
|
public health and safety |
5 |
|
ras gtpase-activating proteins - metabolism |
5 |
|
rassf1a |
5 |
|
rassf2a |
5 |
|
repressor proteins - metabolism |
5 |
|
rna, messenger - genetics - metabolism |
5 |
|
screening |
5 |
|
sensitivity and specificity |
5 |
|
serms |
5 |
|
squamous intraepithelial lesion |
5 |
|
standardized uptake value |
5 |
|
statistics, nonparametric |
5 |
|
survival |
5 |
|
tgf-β |
5 |
|
tissue array analysis |
5 |
|
tissue microarray |
5 |
|
transforming growth factor beta - pharmacology |
5 |
|
trophoblastic neoplasms - metabolism - pathology |
5 |
|
tumor markers, biological - genetics |
5 |
|
tumor suppressor proteins |
5 |
|
tumor suppressor proteins - metabolism |
5 |
|
tumor virus infections - diagnosis |
5 |
|
up-regulation |
5 |
|
uterine cervical neoplasms - blood - enzymology - genetics |
5 |
|
uterine cervical neoplasms - diagnosis - prevention & control |
5 |
|
uterine cervical neoplasms - ethnology - genetics - virology |
5 |
|
uterine neoplasms - diagnosis - genetics - pathology |
5 |
|
uterine neoplasms - genetics - metabolism - pathology |
5 |
|
uterine neoplasms - genetics - pathology - surgery |
5 |
|
uterine neoplasms - metabolism - pathology |
5 |
|
uterine sarcoma |
5 |
|
vin |
5 |
|
viral dna integration |
5 |
|
virus integration - genetics |
5 |
|
vulvar cancer |
5 |
|
vulvar dystrophy |
5 |
|
young adult |
5 |
|
adaptor proteins, signal transducing - genetics |
4 |
|
adenocarcinoma - enzymology |
4 |
|
adenocarcinoma - genetics |
4 |
|
adenocarcinoma - metabolism - pathology |
4 |
|
akt |
4 |
|
alleles |
4 |
|
amp-activated protein kinases |
4 |
|
ampk |
4 |
|
antigens, neoplasm |
4 |
|
autophagy |
4 |
|
b-catenin |
4 |
|
bcl-2-associated x protein |
4 |
|
beta catenin - metabolism |
4 |
|
blotting, southern |
4 |
|
brca1 |
4 |
|
breast neoplasms - genetics |
4 |
|
cadherin-11 |
4 |
|
cadherins - antagonists and inhibitors - genetics - physiology |
4 |
|
cadherins - biosynthesis - metabolism |
4 |
|
cancer stem cells |
4 |
|
candidate cancer genes |
4 |
|
carcinoma - genetics - pathology |
4 |
|
carcinoma, squamous cell - diagnosis - enzymology - virology |
4 |
|
carcinoma, squamous cell - enzymology |
4 |
|
catenins - genetics - metabolism - physiology |
4 |
|
cell cycle |
4 |
|
cell invasion |
4 |
|
cell line |
4 |
|
centromere |
4 |
|
cervical cancers |
4 |
|
cervical cytology |
4 |
|
cervical intraepithelial neoplasia - diagnosis - enzymology - pathology - virology |
4 |
|
cervix uteri - metabolism |
4 |
|
chemotherapy |
4 |
|
choriocarcinoma - genetics - metabolism |
4 |
|
choriocarcinoma - genetics - pathology |
4 |
|
chorionic gonadotropin, beta subunit, human - metabolism |
4 |
|
chromosomal proteins, non-histone - genetics |
4 |
|
chromosome |
4 |
|
chromosomes, human, pair 11 |
4 |
|
chromosomes, human, pair 12 |
4 |
|
chromosomes, human, pair 17 |
4 |
|
chromosomes, human, pair 5 - genetics |
4 |
|
cloning, molecular |
4 |
|
colposcopy |
4 |
|
concurrent methylation |
4 |
|
cross-sectional studies |
4 |
|
cytogenetic study |
4 |
|
cytogenetics |
4 |
|
cytoplasm - enzymology |
4 |
|
death- associated protein kinase |
4 |
|
differential gene expression |
4 |
|
disease-free survival |
4 |
|
dna - chemistry |
4 |
|
dna primers - chemistry |
4 |
|
dna primers - genetics |
4 |
|
dna, complementary - metabolism |
4 |
|
dna, mitochondrial - genetics |
4 |
|
dna, neoplasm - metabolism |
4 |
|
dna-directed dna polymerase - genetics |
4 |
|
down-regulation |
4 |
|
educational status |
4 |
|
endometrial cancers |
4 |
|
endometrial neoplasms - genetics |
4 |
|
endometrial neoplasms - genetics - metabolism - pathology |
4 |
|
endometrial neoplasms - genetics - pathology - ultrastructure |
4 |
|
endometrial neoplasms - pathology - physiopathology |
4 |
|
estrogen receptor alpha - genetics - metabolism |
4 |
|
estrogen receptor beta - genetics - metabolism |
4 |
|
extravillous trophoblast |
4 |
|
first-trimester |
4 |
|
follistatin-related proteins - genetics - physiology |
4 |
|
gene dosage |
4 |
|
gene expression profiling - methods |
4 |
|
gene expression regulation, neoplastic - genetics |
4 |
|
genes, brca1 |
4 |
|
genes, brca2 |
4 |
|
genetic markers |
4 |
|
genomic instability - genetics |
4 |
|
gestational trophoblastic disease - genetics - metabolism - pathology |
4 |
|
gestational trophoblastic disease - genetics - pathology |
4 |
|
gestational trophoblastic diseases |
4 |
|
gestational trophoblastic neoplasms - genetics - pathology - therapy |
4 |
|
gnrh |
4 |
|
gpi-linked proteins |
4 |
|
gtp-binding proteins - metabolism |
4 |
|
gynecologic cancer |
4 |
|
gynecologic oncology |
4 |
|
gynecological cancers |
4 |
|
health knowledge, attitudes, practice |
4 |
|
health surveys |
4 |
|
hedgehog proteins - metabolism |
4 |
|
hela cells |
4 |
|
high-grade squamous intraepithelial lesions |
4 |
|
homeodomain proteins - genetics - metabolism |
4 |
|
hpv vaccine |
4 |
|
hpv vaccine perception |
4 |
|
hpv vaccine questionnaire |
4 |
|
hpv vaccine survey |
4 |
|
hydatidiform mole - genetics - metabolism - pathology |
4 |
|
hydatidiform mole - genetics - pathology |
4 |
|
hydatidiform mole - metabolism |
4 |
|
igf-1r |
4 |
|
igfbp3 |
4 |
|
in situ nick-end labeling |
4 |
|
interphase |
4 |
|
low-grade squamous intraepithelial lesions |
4 |
|
ly294002 |
4 |
|
mass screening - methods |
4 |
|
membrane glycoproteins - genetics - metabolism |
4 |
|
metformin |
4 |
|
methylation profile |
4 |
|
microsatellite instability analysis |
4 |
|
mismatch repair deficiency |
4 |
|
mitochondrial dna |
4 |
|
mitochondrial microsatellite instability |
4 |
|
motility |
4 |
|
mtor |
4 |
|
multienzyme complexes - genetics |
4 |
|
neoplasm proteins - analysis |
4 |
|
neoplasm proteins - genetics - metabolism |
4 |
|
neoplasm recurrence, local |
4 |
|
neoplastic stem cells - physiology |
4 |
|
notch |
4 |
|
nuclear proteins - genetics |
4 |
|
oncogene proteins, viral - biosynthesis |
4 |
|
osteopontin |
4 |
|
ovarian neoplasms - enzymology - genetics - pathology |
4 |
|
ovarian neoplasms - genetics - metabolism |
4 |
|
ovarian neoplasms - pathology - physiopathology |
4 |
|
ovarian tumors |
4 |
|
ovary - cytology - metabolism |
4 |
|
ovary - metabolism |
4 |
|
ovary - pathology |
4 |
|
p-cadherin |
4 |
|
p120ctn |
4 |
|
p21-activated kinases - antagonists and inhibitors - genetics - physiology |
4 |
|
pak1 |
4 |
|
pak2 |
4 |
|
papillomaviridae - genetics |
4 |
|
papillomaviridae - immunology |
4 |
|
papillomavirus e7 proteins |
4 |
|
papillomavirus infections - complications - enzymology - genetics |
4 |
|
papillomavirus infections - prevention & control - virology |
4 |
|
papillomavirus vaccines |
4 |
|
pilot projects |
4 |
|
placenta - cytology |
4 |
|
placenta - physiology |
4 |
|
placental site trophoblastic tumor |
4 |
|
polymerase chain reaction - methods |
4 |
|
polymorphism, single nucleotide - genetics |
4 |
|
predictive value of tests |
4 |
|
pregnancy complications, infectious - diagnosis - enzymology - virology |
4 |
|
pregnancy trimester, first |
4 |
|
pregnancy trimesters |
4 |
|
prkaa1 |
4 |
|
prognostic marker |
4 |
|
prospective studies |
4 |
|
prostate stem cell antigen |
4 |
|
prostatic neoplasms - genetics - metabolism - pathology |
4 |
|
protein-serine-threonine kinases - genetics |
4 |
|
proto-oncogene proteins c-bcl-2 - metabolism |
4 |
|
quality of life |
4 |
|
questionnaires |
4 |
|
radiation tolerance - genetics |
4 |
|
receptor, igf type 1 - antagonists and inhibitors - genetics - physiology |
4 |
|
receptors, cell surface - metabolism |
4 |
|
receptors, fsh - genetics |
4 |
|
reverse transcriptase polymerase chain reaction - methods |
4 |
|
rho gtp-binding proteins - metabolism |
4 |
|
rna - metabolism |
4 |
|
rna, messenger - biosynthesis - genetics |
4 |
|
rna-binding proteins - genetics - metabolism |
4 |
|
sarcoma, endometrial stromal - genetics - pathology - ultrastructure |
4 |
|
semi-quantitative fluorescent differential pcr |
4 |
|
sialoglycoproteins - metabolism |
4 |
|
signal transduction - genetics |
4 |
|
signal transduction - physiology |
4 |
|
stemness |
4 |
|
sulfites - chemistry |
4 |
|
suppression subtractive hybridization |
4 |
|
telomerase |
4 |
|
telomerase - analysis |
4 |
|
telomerase - metabolism |
4 |
|
telomerase repeat amplification protocol |
4 |
|
telomere - enzymology - genetics |
4 |
|
temperature |
4 |
|
tgfβ |
4 |
|
therapeutic target |
4 |
|
time factors |
4 |
|
transcription factors - metabolism |
4 |
|
transforming growth factor beta - physiology |
4 |
|
transforming growth factor beta1 |
4 |
|
treatment outcome |
4 |
|
trf |
4 |
|
trophoblastic tumor, placental site - genetics - metabolism - pathology |
4 |
|
trophoblasts - physiology |
4 |
|
tumor suppressor genes |
4 |
|
tumor suppressor protein p53 - genetics - metabolism |
4 |
|
uterine cervical dysplasia - diagnosis - enzymology - pathology - virology |
4 |
|
uterine cervical neoplasms - diagnosis - enzymology - pathology - virology |
4 |
|
uterine cervical neoplasms - enzymology |
4 |
|
uterine cervical neoplasms - enzymology - genetics - virology |
4 |
|
uterine cervical neoplasms - metabolism - radiotherapy |
4 |
|
uterine cervical neoplasms - prevention & control - virology |
4 |
|
uterine cervicitis - enzymology - pathology - virology |
4 |
|
uterine neoplasms - genetics - metabolism |
4 |
|
uterine neoplasms - genetics - pathology |
4 |
|
x chromosome |
4 |
|
abortion, spontaneous - metabolism |
3 |
|
adaptor proteins, signal transducing - genetics - metabolism |
3 |
|
adenocarcinoma |
3 |
|
adenocarcinoma - pathology |
3 |
|
adenocarcinoma, clear cell - drug therapy - pathology - radiotherapy |
3 |
|
adenocarcinoma, clear cell - genetics - pathology |
3 |
|
adenocarcinoma, clear cell - pathology - therapy |
3 |
|
age factors |
3 |
|
aicar |
3 |
|
ais |
3 |
|
alphapapillomavirus - isolation and purification |
3 |
|
amp-activated protein kinase |
3 |
|
antineoplastic agents - therapeutic use |
3 |
|
antineoplastic agents, phytogenic - pharmacology |
3 |
|
antineoplastic combined chemotherapy protocols - administration & dosage |
3 |
|
antineoplastic combined chemotherapy protocols - adverse effects - therapeutic use |
3 |
|
anxiety - etiology |
3 |
|
apoferritins |
3 |
|
apoptotic (ai) and mitotic indices (mi) |
3 |
|
apoptotic activity |
3 |
|
asian women |
3 |
|
aspp1 |
3 |
|
attitude to health |
3 |
|
atypical cytology |
3 |
|
bcl2a1 |
3 |
|
beliefs |
3 |
|
beta-catenin |
3 |
|
biopsy, needle |
3 |
|
brachytherapy - methods |
3 |
|
brain-derived neurotrophic factor - biosynthesis |
3 |
|
brenner tumor - diagnosis - metabolism - pathology |
3 |
|
brenner tumour |
3 |
|
c-erbb-2 |
3 |
|
c-erbb2 |
3 |
|
c-fms |
3 |
|
c-kit |
3 |
|
c-myc |
3 |
|
ca 125 |
3 |
|
ca125 |
3 |
|
camkk |
3 |
|
carboplatin |
3 |
|
carcinoma - enzymology - mortality - pathology |
3 |
|
carcinoma in situ - pathology |
3 |
|
carcinoma, squamous cell - genetics - mortality - surgery - virology |
3 |
|
carcinoma, squamous cell - metabolism - mortality - virology |
3 |
|
carcinoma, transitional cell - diagnosis - metabolism - pathology |
3 |
|
caspase |
3 |
|
cell movement |
3 |
|
cell movement - genetics |
3 |
|
cell movement - physiology |
3 |
|
cervical carcinoma and prognosis |
3 |
|
cervical intraepithelial neoplasia - genetics - metabolism |
3 |
|
cervix uteri - pathology - virology |
3 |
|
chemoirradiation |
3 |
|
chinese women |
3 |
|
choriocarcinoma - genetics - metabolism - pathology |
3 |
|
choriocarcinoma - metabolism |
3 |
|
choriocarcinoma, non-gestational - pathology - therapy |
3 |
|
choriocarcinomas |
3 |
|
cin |
3 |
|
clear cell adenocarcinoma |
3 |
|
clear cell carcinoma |
3 |
|
combined modality therapy |
3 |
|
copy number |
3 |
|
cystadenocarcinoma, mucinous - genetics - pathology |
3 |
|
cystadenocarcinoma, serous - genetics - pathology |
3 |
|
cystadenoma - enzymology - mortality - pathology |
3 |
|
d-loop |
3 |
|
daidzein |
3 |
|
dinucleotide repeats |
3 |
|
dna amplification |
3 |
|
dna replication - genetics |
3 |
|
dna, complementary - genetics |
3 |
|
dna, mitochondrial - blood - genetics |
3 |
|
dna, mitochondrial - genetics - isolation & purification - metabolism |
3 |
|
dna, mitochondrial - genetics - metabolism |
3 |
|
dna, neoplasm - blood - genetics |
3 |
|
dock180 expression |
3 |
|
drugs, chinese herbal - adverse effects - therapeutic use |
3 |
|
egfr |
3 |
|
endometrial neoplasms - virology |
3 |
|
enzymes - genetics |
3 |
|
epidermal growth factor receptor |
3 |
|
epithelial cells - metabolism - pathology |
3 |
|
epithelioid trophoblastc tumour |
3 |
|
erb-041 |
3 |
|
esophageal neoplasms - genetics - mortality - surgery - virology |
3 |
|
esophagectomy |
3 |
|
esophagus - virology |
3 |
|
exons |
3 |
|
ferritins |
3 |
|
follow-up |
3 |
|
ftl |
3 |
|
gemcitabine |
3 |
|
gene deletion |
3 |
|
gene expression regulation, neoplastic - radiation effects |
3 |
|
genistein |
3 |
|
genome, human |
3 |
|
globins - genetics |
3 |
|
grb7 |
3 |
|
gynecologic surgical procedures |
3 |
|
hpv testing |
3 |
|
hpv vaccination |
3 |
|
hydatidiform mole - genetics - metabolism |
3 |
|
hypermethylation |
3 |
|
hypoxia |
3 |
|
igfbp1 |
3 |
|
immune function |
3 |
|
incidence |
3 |
|
individuality |
3 |
|
inhibitor of apoptotic protein (iap) |
3 |
|
insulin-like growth factor binding protein 1 - genetics |
3 |
|
intrinsic cell apoptosis |
3 |
|
invasion |
3 |
|
ki-67 index |
3 |
|
knowledge |
3 |
|
laser capture microdissection |
3 |
|
leep |
3 |
|
lkb1 |
3 |
|
lletz |
3 |
|
longitudinal |
3 |
|
lymphocytes - metabolism |
3 |
|
m30 |
3 |
|
membrane proteins - biosynthesis |
3 |
|
membrane proteins - genetics - metabolism |
3 |
|
mesoderm - metabolism - pathology |
3 |
|
metastasis |
3 |
|
mi/ai ratio |
3 |
|
microsatellite instability |
3 |
|
microscopy, confocal |
3 |
|
mirna |
3 |
|
mitochondria - genetics |
3 |
|
mitosis - drug effects |
3 |
|
mitotic index |
3 |
|
monotherapy |
3 |
|
neoadjuvant chemotherapy |
3 |
|
neoplasm grading |
3 |
|
neoplasm invasiveness - genetics - pathology |
3 |
|
neoplasm invasiveness - pathology |
3 |
|
neoplasm proteins/genetics |
3 |
|
neovascularization, pathologic - genetics - metabolism |
3 |
|
nongestatational choriocarcinoma |
3 |
|
normal cervix |
3 |
|
oligonucleotide array sequence analysis - methods |
3 |
|
ovarian cancer recurrence |
3 |
|
ovarian neoplasms - diagnosis - metabolism - pathology |
3 |
|
ovarian neoplasms - drug therapy - immunology |
3 |
|
ovarian neoplasms - drug therapy - metabolism - pathology |
3 |
|
ovarian neoplasms - enzymology - mortality - pathology |
3 |
|
ovarian neoplasms - metabolism - mortality - pathology |
3 |
|
ovarian neoplasms - pathology - therapy |
3 |
|
ovarian neoplasms - virology |
3 |
|
ovarian tumours |
3 |
|
p21-activated kinases - antagonists and inhibitors - genetics - metabolism |
3 |
|
p53 codon 72 polymorphism |
3 |
|
paclitaxel |
3 |
|
paclitaxel - pharmacology |
3 |
|
pan-ras |
3 |
|
papillomaviridae - genetics - isolation & purification |
3 |
|
papillomavirus infections - complications - epidemiology - virology |
3 |
|
papillomavirus infections - diagnosis - psychology |
3 |
|
papillomavirus infections - epidemiology - mortality |
3 |
|
papillomavirus infections - ethnology - prevention & control - psychology |
3 |
|
papillomavirus vaccines - therapeutic use |
3 |
|
patient acceptance of health care |
3 |
|
patient satisfaction - ethnology |
3 |
|
peptides - genetics |
3 |
|
peritoneal metastases |
3 |
|
physical examination |
3 |
|
placenta |
3 |
|
placental site trophoblastic tumour |
3 |
|
polymorphism, single-stranded conformational |
3 |
|
post lletz complications |
3 |
|
pregnancy complications - metabolism - pathology |
3 |
|
pregnancy complications, neoplastic - genetics |
3 |
|
prevention |
3 |
|
prognostic factor |
3 |
|
proto-oncogenes - physiology |
3 |
|
psychology |
3 |
|
psychosocial adjustment |
3 |
|
rac gtp-binding proteins - analysis - biosynthesis |
3 |
|
rare diseases |
3 |
|
real-time polymerase chain reaction |
3 |
|
real-time quantitative pcr |
3 |
|
receptor, epidermal growth factor - metabolism |
3 |
|
receptor, erbb-2 - metabolism |
3 |
|
receptor, trkb - biosynthesis |
3 |
|
repressor proteins |
3 |
|
repressor proteins - biosynthesis - genetics |
3 |
|
ribonuclease protection assay |
3 |
|
ribosomal protein s6 kinases, 70-kda - physiology |
3 |
|
risk assessment |
3 |
|
rna, neoplasm - analysis |
3 |
|
rna, ribosomal - genetics |
3 |
|
rna, ribosomal, 16s - genetics |
3 |
|
rna, small interfering |
3 |
|
sox2 |
3 |
|
sox7 |
3 |
|
soxb1 transcription factors - genetics - metabolism |
3 |
|
staging |
3 |
|
stress, psychological - etiology |
3 |
|
surgery |
3 |
|
survival rate |
3 |
|
terminal deoxynucleotidyl transferase (tdt)-mediated deoxyuracil triphosphate (dutp) nick-end labelling (tunel) |
3 |
|
timp3 |
3 |
|
tp53 |
3 |
|
traditional chinese medicine |
3 |
|
transfection |
3 |
|
transitional cell carcinoma |
3 |
|
trkb |
3 |
|
trophoblastic neoplasms - genetics |
3 |
|
trophoblastic tumor, placental site - metabolism - pathology |
3 |
|
trophoblasts - metabolism - physiology |
3 |
|
tumor suppressor protein p53 - metabolism |
3 |
|
tumor virus infections - epidemiology - mortality |
3 |
|
tumorigenicity |
3 |
|
uterine cervical neoplasms - drug therapy - pathology - radiotherapy |
3 |
|
uterine cervical neoplasms - ethnology - virology |
3 |
|
uterine cervical neoplasms - genetics - metabolism |
3 |
|
uterine cervical neoplasms - genetics - mortality - pathology - radiotherapy |
3 |
|
uterine cervical neoplasms - genetics - virology |
3 |
|
uterine cervical neoplasms - metabolism - mortality - virology |
3 |
|
uterine cervical neoplasms - pathology |
3 |
|
uterine cervical neoplasms - prevention and control - virology |
3 |
|
uterine cervical neoplasms - virology |
3 |
|
uterine neoplasms - genetics |
3 |
|
viral load |
3 |
|
wnt |
3 |
|
women's health issues |
3 |
|
"favor neoplasia" |
2 |
|
"nos" |
2 |
|
3d ultrasound |
2 |
|
adenocarcinoma - diagnosis - pathology |
2 |
|
adenocarcinoma - etiology - metabolism |
2 |
|
adenocarcinoma - virology |
2 |
|
adenosarcoma |
2 |
|
adenoviral vector |
2 |
|
agc |
2 |
|
agus |
2 |
|
angiography |
2 |
|
antisense oligonucleotide |
2 |
|
apoptosis - physiology |
2 |
|
arteries - surgery |
2 |
|
asia |
2 |
|
asia - epidemiology |
2 |
|
asia pacific |
2 |
|
asian continental ancestry group |
2 |
|
atp cell viability assay |
2 |
|
attitudes |
2 |
|
bar |
2 |
|
bcl-2 |
2 |
|
biopsy - statistics & numerical data |
2 |
|
breast carcinoma |
2 |
|
ca-125 antigen - blood |
2 |
|
ca-19-9 antigen - blood |
2 |
|
ca15.3 |
2 |
|
ca19.9 |
2 |
|
capsid proteins |
2 |
|
carcinoma in situ - diagnosis - pathology |
2 |
|
carcinoma, squamous cell - epidemiology - genetics - virology |
2 |
|
carcinoma, squamous cell - epidemiology - prevention & control - virology |
2 |
|
cervical cancer cell lines |
2 |
|
cervical carcinoma |
2 |
|
cervical intraepithelial neoplasia - diagnosis - pathology |
2 |
|
cervical intraepithelial neoplasia - pathology - therapy |
2 |
|
cervical intraepithelial neoplasia - prevention & control - psychology |
2 |
|
cervical intraepithelial neoplasia - prevention & control - virology |
2 |
|
cervix |
2 |
|
cervix uteri - pathology |
2 |
|
chinese adolescent girls |
2 |
|
cisplatin |
2 |
|
clinical trials as topic |
2 |
|
consensus sequence |
2 |
|
conservative treatment |
2 |
|
consumer health information - methods |
2 |
|
cost |
2 |
|
cytology |
2 |
|
dna, viral - analysis - genetics |
2 |
|
embolization, therapeutic |
2 |
|
endometrial and ovarian carcinomas |
2 |
|
endometrial hyperplasia - diagnosis - pathology |
2 |
|
endometrial neoplasms - diagnosis - surgery - therapy |
2 |
|
epidemiology |
2 |
|
esophageal neoplasms - epidemiology - genetics - virology |
2 |
|
esophagus |
2 |
|
gene expression regulation, neoplastic - physiology |
2 |
|
gene transfer |
2 |
|
genes, bcl-2 |
2 |
|
genital neoplasms, female - pathology |
2 |
|
gestational trophoblastic disease - complications - epidemiology |
2 |
|
gestational trophoblastic neoplasms |
2 |
|
health personnel |
2 |
|
healthcare providers |
2 |
|
hemostatic techniques - utilization |
2 |
|
histology |
2 |
|
hpv dna |
2 |
|
hpv education |
2 |
|
human papillomavirus testing |
2 |
|
hysterectomy |
2 |
|
intermediate filament proteins - metabolism |
2 |
|
intestinal metaplasia |
2 |
|
keratin-20 |
2 |
|
keratin-7 |
2 |
|
laser-captured micro-dissection |
2 |
|
ligation |
2 |
|
low grade squamous intraepithelial lesions (lsil) |
2 |
|
lymphocyst |
2 |
|
medical records |
2 |
|
meta-analysis |
2 |
|
methyltransferase |
2 |
|
mitochondrial dna alterations |
2 |
|
mitomycin c |
2 |
|
mole |
2 |
|
msp |
2 |
|
mucin-1 - blood |
2 |
|
nucleic acid hybridization |
2 |
|
observer variation |
2 |
|
oncogene proteins, viral - genetics |
2 |
|
oncogene proteins, viral - isolation & purification |
2 |
|
oncology |
2 |
|
papillomavirus infections - complications - virology |
2 |
|
papillomavirus infections - epidemiology - prevention & control - virology |
2 |
|
papillomavirus infections - prevention & control - psychology |
2 |
|
papillomavirus infections - prevention and control |
2 |
|
papillomavirus vaccines - administration & dosage |
2 |
|
pathology review |
2 |
|
patient acceptance of health care - ethnology |
2 |
|
pcr |
2 |
|
pelvic lymphadenectomy |
2 |
|
placental-site trophoblastic tumour |
2 |
|
plasma dna |
2 |
|
prb |
2 |
|
proto-oncogene proteins - genetics |
2 |
|
proto-oncogene proteins c-bcl-2 - genetics |
2 |
|
quantitative pcr |
2 |
|
radiography, interventional |
2 |
|
radiosensitivity |
2 |
|
recurrence |
2 |
|
referral and consultation |
2 |
|
remission, spontaneous |
2 |
|
safety |
2 |
|
school-based health education |
2 |
|
selective |
2 |
|
serum |
2 |
|
sexual behavior |
2 |
|
significant pathology |
2 |
|
singapore |
2 |
|
social stigma |
2 |
|
spot and early morning urine |
2 |
|
squamous cell carcinoma |
2 |
|
sscp |
2 |
|
stigma |
2 |
|
taiwan |
2 |
|
therapeutic embolization |
2 |
|
treatment |
2 |
|
trophoblastic tumor, placental site - genetics - pathology |
2 |
|
tumor markers, biological |
2 |
|
tumor virus infections - complications - virology |
2 |
|
type distribution |
2 |
|
undifferentiated endometrial sarcoma |
2 |
|
urethral adenocarcinoma |
2 |
|
urethral neoplasms - etiology - metabolism |
2 |
|
urethritis - complications |
2 |
|
urethritis glandularis |
2 |
|
urinary hcg-beta-core |
2 |
|
uterine bleeding |
2 |
|
uterine cervical dysplasia - pathology - therapy |
2 |
|
uterine cervical neoplasms - diagnosis - pathology |
2 |
|
uterine cervical neoplasms - epidemiology - prevention & control - virology |
2 |
|
uterine cervical neoplasms - ethnology - prevention and control - virology |
2 |
|
uterine cervical neoplasms - pathology - therapy |
2 |
|
uterine hemorrhage - etiology - radiography - therapy |
2 |
|
uterine neoplasms - complications - epidemiology |
2 |
|
vaginal smears - statistics & numerical data |
2 |
|
age distribution |
1 |
|
aids |
1 |
|
amifostine |
1 |
|
antibiotics, antineoplastic - therapeutic use |
1 |
|
antigens, neoplasm - blood |
1 |
|
anxiety |
1 |
|
anxiety - etiology - prevention & control |
1 |
|
ascites |
1 |
|
ca-125 |
1 |
|
carcinoma, squamous cell - immunology |
1 |
|
cervical cancer control |
1 |
|
cervical intraepithelial neoplasia - prevention & control |
1 |
|
cervical punch biopsy |
1 |
|
cervix cancer |
1 |
|
chemosensitivity |
1 |
|
chemotherapy, adjuvant |
1 |
|
chorionic gonadotropin - blood |
1 |
|
chorionic gonadotropin - metabolism |
1 |
|
classification |
1 |
|
colposcopy - methods - psychology |
1 |
|
complementary and alternative medicine |
1 |
|
cost-benefit analysis |
1 |
|
cost-effective |
1 |
|
counseling |
1 |
|
counselling |
1 |
|
ct |
1 |
|
ct thorax |
1 |
|
cytotoxicity |
1 |
|
dactinomycin - therapeutic use |
1 |
|
drug response |
1 |
|
endometrial neoplasms - pathology - surgery |
1 |
|
exenteration |
1 |
|
extrauterine involvement |
1 |
|
figo |
1 |
|
gestational trophoblastic disease - diagnosis - pathology - radiography - therapy |
1 |
|
gestational trophoblastic disease - drug therapy - metabolism |
1 |
|
gestational trophoblastic tumor (gtt) |
1 |
|
glycosylation |
1 |
|
gtn |
1 |
|
gynecologic cancer patients |
1 |
|
hcg |
1 |
|
health education - organization & administration - trends |
1 |
|
health personnel - education |
1 |
|
health policy - trends |
1 |
|
health services accessibility - trends |
1 |
|
health-care professionals |
1 |
|
hepatic arteriogram (hag) |
1 |
|
hiv screening |
1 |
|
human papillomavirus 16 |
1 |
|
human papillomavirus 18 |
1 |
|
human rights |
1 |
|
hydatidiform mole - blood |
1 |
|
klf2 |
1 |
|
liver metastasis |
1 |
|
liver neoplasms - blood supply - radiography - secondary - therapy |
1 |
|
maternal health services - organization & administration - trends |
1 |
|
metastases |
1 |
|
methotrexate - therapeutic use |
1 |
|
micrometastasis |
1 |
|
molar pregnancy |
1 |
|
monitoring |
1 |
|
monitoring, immunologic - economics - methods |
1 |
|
monsel's solution |
1 |
|
mr imaging |
1 |
|
myelotoxicity |
1 |
|
neoplasm recurrence, local - immunology |
1 |
|
neoplasm recurrence, local - prevention & control |
1 |
|
neoplasm staging - methods |
1 |
|
neutropenia |
1 |
|
ovarian neoplasms - classification - diagnosis - mortality - therapy |
1 |
|
ovarian tumors of low malignant potential |
1 |
|
ovariectomy |
1 |
|
papillomavirus infections - complications - genetics |
1 |
|
papillomavirus vaccines - immunology |
1 |
|
patient compliance |
1 |
|
patient education as topic |
1 |
|
pelvic exenteration |
1 |
|
peritoneal cytology |
1 |
|
persistent trophoblastic tumour (pit) |
1 |
|
platinum-resistant epithelial ovarian cancer |
1 |
|
postoperative period |
1 |
|
proportional hazards models |
1 |
|
radiotherapy |
1 |
|
radiotherapy, adjuvant |
1 |
|
recurrent ovarian cancer |
1 |
|
sarcoma - pathology - therapy |
1 |
|
scc |
1 |
|
second opinion |
1 |
|
serpins |
1 |
|
serum human chorionic gonadotrophin (hcg) monitoring |
1 |
|
stage ia pgtd |
1 |
|
struma ovarii |
1 |
|
topotecan |
1 |
|
transcriptional regulation |
1 |
|
trophoblastic neoplasms - blood - diagnosis - drug therapy |
1 |
|
uterine cervical neoplasms - immunology |
1 |
|
uterine cervical neoplasms - mortality - therapy |
1 |
|
uterine cervical neoplasms - prevention & control |
1 |
|
uterine neoplasms - blood - diagnosis - drug therapy |
1 |
|
uterine neoplasms - pathology - therapy |
1 |
|
vaccination |
1 |
|
vaccine |
1 |
|
vagina - pathology |
1 |
|
vaginal bleeding |
1 |
|
vaginal neoplasms - classification - diagnosis - mortality - therapy |
1 |
|
vaginal sarcoma |
1 |
|
value of life |
1 |
|
wee1 |
1 |
|
women over 25 years |
1 |
|
women's rights |
1 |
|
women's rights - education - trends |
1 |
